Deaths Prompt Clinical Trial Hold; $8,000 Scorpion Bite; The Next COVID Vaccine

(MedPage Today) — Note that some links may require registration or subscription.
After patient deaths from interstitial lung disease in a lung cancer trial testing the antibody-drug conjugate ifinatamab deruxtecan, the FDA placed a partial hold…